Medical Oncologist
CION Cancer Clinics
Why a bigger gene panel is not always the better test | CION Cancer Clinics
A bigger panel is not automatically a better test. Each extra gene adds a small chance of a useful answer and a larger chance of a result nobody can explain. The right panel covers the genes that fit your family's cancers, plus the well-proven genes where a fault would change care. This page explains the hidden costs of testing more genes, and when a wider test is worth it. At CION Cancer Clinics in Hyderabad, our oncologists review your family history with you and guide you to the right genetic counselling and testing.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Why would a test with more genes not be better?
- What does a bigger panel quietly add to your report?
- How does a counsellor decide which genes to test?
- The words behind this debate, in plain language
- Focused panel or very large panel: what is the trade?
- What this page cannot tell you
- Four things families assume about panel size
- Common questions about panel size
The short answer
Why would a test with more genes not be better?
Because every extra gene brings extra doubt along with it. A bigger panel finds slightly more real faults, but it finds many more results that nobody can yet explain. The best panel is the one that fits your family's history, not the longest list a laboratory can sell.
What a gene has to earn to be worth testing
A gene is worth reading when three things are true. Its link to cancer is well proven. A fault in it would change what doctors do, such as starting scans earlier. And it fits the cancers seen in your family. Many genes on the largest panels meet only one of those tests, or none.
When a wider test does make sense
A wider panel can be the right call. It helps when the family has an unusual mix of cancers, when a strong history has already tested negative, or when a counsellor suspects a rare syndrome. In those cases the extra doubt is a price worth paying, and the counsellor will say so plainly.
The question is never how many genes. It is which genes, and why.The hidden costs
What does a bigger panel quietly add to your report?
None of these costs show on the price list. Each of them can land on the family long after the test is paid for.
More uncertain results
The more genes read, the more likely the lab finds a spelling change it cannot classify. This is a variant of uncertain significance, and it is not a positive result. It can still cause months of worry.
Genes with weak evidence
Some genes sit on panels because early research suggested a link to cancer. That link may not have held up. A fault in such a gene tells you very little about your real risk.
Findings that change nothing
A real fault can turn up in a gene with no agreed screening plan. You then carry the knowledge without a clear next step, which many people find harder than not knowing.
This can lead to
- Extra scans that were never shown to help
- Anxiety spread to brothers, sisters and children
- Pressure to act on a result that does not justify it
Knock-on testing in the family
Relatives may be tested for a fault of doubtful importance. Every one of those tests carries its own cost, wait and worry, and none of them settles the original question.
Not sure whether this applies to you?
Ask an oncologistChoosing the size
How does a counsellor decide which genes to test?
Start with the question
Is the family asking about breast and ovarian cancer, bowel and womb cancer, or something rarer? The question decides the genes, not the other way round.
Read the family tree
Which cancers, on which side, at what ages. A cluster of young breast cancers points to different genes than a run of stomach cancers.
Keep the genes that change care
Genes with a proven link and an agreed plan go on the list. These are the genes where a result would change scans, surgery choices or treatment.
Add only what the history supports
Extra genes are added when something in the family points to them, such as an unusual cancer or a known syndrome in a relative.
Agree what happens with doubt
Before the sample is taken, you agree how uncertain results will be handled and how you will hear if one is reclassified later.
On your report
The words behind this debate, in plain language
- Panel
- A test that reads a chosen list of genes at once, rather than one gene at a time.
- Variant of uncertain significance
- Often shortened to VUS. A spelling change the lab cannot yet call harmful or harmless. It should not change treatment.
- Actionable gene
- A gene where a fault leads to a clear, agreed step, such as earlier scans or a particular medicine.
- Moderate-risk gene
- A gene whose faults raise risk less sharply than the best-known genes. Advice often leans on family history as much as on the result.
- Gene–disease validity
- How strong the evidence is that a gene truly causes a cancer. Expert groups such as ClinGen grade this openly.
- Reclassification
- When a lab changes its verdict on a variant as new evidence arrives. Most uncertain results that change turn out to be harmless.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
Focused panel or very large panel: what is the trade?
Focused panel matched to your history
Very large panel
Fewer uncertain results
Many more uncertain results
Every gene has an agreed plan if a fault is found
Some genes have no agreed plan at all
Relatives tested only for faults that matter
Relatives may be tested for doubtful faults
May miss a rare cause outside the list
Catches a rare cause slightly more often
Being straight with you
What this page cannot tell you
It cannot tell you which genes belong on your test. That depends on your family tree, the cancers in it and what has already been tested. A genetic counsellor or clinical geneticist makes that call with you.
It cannot explain a result you already have
If a big panel has already found an uncertain change or a fault in a little-known gene, do not act on it alone. What your specific variant means is a question for the counsellor who ordered the test. No preventive surgery should rest on an uncertain result.
Why doubt runs higher for Indian families
The large variant databases hold far fewer Indian samples than European ones. A harmless change common in Telangana can look rare on a report, so uncertain results tend to be more frequent here. Evidence from Indian studies is growing but still thin.
Who this does not apply to
Most people do not need any genetic test at all. This page is for families who have already been told testing makes sense.
Offered a panel and unsure about its size? Call the helpline and ask. We will explain what each gene is there for.Commonly believed
Four things families assume about panel size
"More genes means a more thorough test."
Thorough means the right genes, read well, including checks for large missing pieces. A focused panel done carefully can be more thorough for your question than a huge one.
"An uncertain result is half a positive."
It is not a positive at all. Most uncertain results that are later reviewed turn out to be harmless. Treatment and surgery decisions should not rest on one.
"If a gene is on the panel, doctors know what to do about it."
Not always. Agreed screening plans exist for some genes and not for others. A fault in a poorly studied gene may leave your doctor with little more than your family history to go on.
"A smaller panel is the cheaper, lesser option."
The size is chosen to fit the question. A counsellor can add genes if the family history supports them, and some labs can look at more genes later from the same sample.
Questions we are asked
Common questions about panel size
How many genes should my panel have?
There is no right number. The right panel covers the genes that fit your family's cancers, plus the well-proven genes where a fault would change care. Your counsellor chooses the list from your family tree. A number on a brochure tells you very little.
Will a bigger panel find more faults?
A few more. Most of the extra finds are in moderate-risk genes, where the advice may barely change. The big rise is in uncertain results. For most families the useful answer comes from a small group of well-known genes.
Why does a bigger panel give more uncertain results?
Everyone carries rare spelling changes. Read more genes and you see more of them. For well-studied genes, labs can usually tell harmful from harmless. For less-studied genes, they often cannot, and the change is reported as uncertain.
The big panel costs almost the same. Should I take it?
Price is only one cost. The others are doubt, extra follow-up and knock-on testing in the family. Some labs let you analyse a chosen group of genes from a larger test. Ask your counsellor before choosing on price alone.
Can more genes be checked later from the same sample?
Sometimes. It depends on the lab, how the test was run and how long they keep your sample or data. Ask before testing whether later analysis is possible and whether it is charged. Keep a copy of your report so any later request is simple.
What if a fault turns up in a gene with weak evidence?
Your counsellor will explain how much it means, which may be very little. Screening is often based on your family history instead. Do not start scans or plan surgery on that result without a specialist's advice, and do not ask relatives to test yet.
Does a bigger panel help choose my cancer treatment?
Rarely. The genes that currently change treatment, such as BRCA1 and BRCA2, are on any good focused panel. Tumour testing to choose medicines is a separate test, covered on our targeted therapy pages. Extra genes seldom change today's treatment.
Who should choose the panel for me?
The genetic counsellor or oncologist who knows your family history. A lab's sales material cannot know which genes fit your family. If a panel has been chosen for you, it is fair to ask why each gene is on it.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NCCN — Genetic/Familial High-Risk Assessment Guidelines
- National Cancer Institute — Genetic Testing for Inherited Cancer Susceptibility Syndromes
- ClinGen — Clinical Genome Resource: gene-disease validity curation
- MedlinePlus Genetics — What do the results of genetic tests mean?
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Offered a panel and not sure it is the right size?
Tell us what test you have been offered and who in the family had cancer. We will explain what each gene is there for and whether the list fits. One helpline serves every CION centre.